Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular alterations and prognosis of breast cancer with cutaneous metastasis.

Diagnostic pathology - 5 Jul 2024

Xu Yan, Ding Li, Li Chao, Hua Bin, Wang Sha, Zhang Junli, Liu Cuicui, Guo Rongyun, Zhang YongQiang

Abstract excerpt

PURPOSE: Cutaneous metastasis (CM) accounts for 5-30% of patients with breast cancer (BC) and presents unfavorable response to treatment and poor prognosis. A better understanding of the molecular alterations involved in metastasis is essential, which would help identify diagnostic and efficacy biomarkers for CM. MATERIALS: We retrospectively reviewed a total of 13 patients with histological or cytological...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to High-Throughput Nucleotide Sequencing

Share to Immunohistochemistry

Share to Prognosis

Share to Skin Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 38970069
DOI: 10.1186/s13000-024-01509-x
PMCID: PMC11225245

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular alterations and prognosis of breast cancer with cutaneous metastasis.PMID 38970069Read ↗

Molecular alterations and prognosis of breast cancer with cutaneous metastasisSemantic proximity Read ↗

Differences in the Molecular Profile between Primary Breast Carcinomas and Their Cutaneous MetastasesSemantic proximity Read ↗

Predictors and outcomes of cutaneous metastatic breast carcinoma: a retrospective, single- institution reviewSemantic proximity Read ↗

The Influence of Cancer Molecular Subtypes and Treatment on the Mutation Spectrum in Metastatic Breast Cancers.Semantic proximity Read ↗

Clinical implications of genomic profiles in metastatic breast cancer with a focus on TP53 and PIK3CA, the most frequently mutated genes.Semantic proximity Read ↗

Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment options.Semantic proximity Read ↗

Genetic alterations associated with multiple primary malignancies.Semantic proximity Read ↗

Distinct clinicopathological characteristics, genomic alteration and prognosis in breast cancer with concurrent TP53 mutation and MYC amplification.Semantic proximity Read ↗

The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors.Semantic proximity Read ↗

Analysis of Genetic Alterations in Cutaneous Malignant Melanomas Unveils Unique Loco-Regional Variations and Novel Predictors of Metastatic Potential.Semantic proximity Read ↗

The Present and Future of Clinical Management in Metastatic Breast CancerSemantic proximity Read ↗

Unique molecular signatures as a hallmark of patients with metastatic breast cancer: Implications for current treatment paradigmsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.